SHK-loaded colloidal mesoporous silica nanoparticles selectively deliver inhibitors to CRC cells, effectively suppressing PKM2 activity and aerobic glycolysis, thereby inhibiting tumor proliferation (87). The gene discussed is PKM; the disease is colorectal carcinoma.